Jiaoze
+86-21-37318802
[email protected]
Sitemap |  RSS |  XML
English English
  • English English
  • Home
  • About Us
    • Company Profile
    • Development History
    • Corporate Culture
  • Products
    • Intermediates And APIs
      • Intermediate
      • Active Pharmaceutical Ingredient
    • Veterinary Drug Service
    • Cosmetics Ingredients
  • News
    • Industry News
    • Company News
  • R&D Services
  • Send Inquiry
  • Contact Us
News
Home News

News

  • Industry News

  • Company News

New Products
  • Shikimic Acid CAS 138-59-0
    Shikimic Acid CAS 138-59-0
  • (R)-3-Piperidinamine dihydrochloride CAS 334618-23-4
    (R)-3-Piperidinamine dihydrochloride CAS 334618-23-4
  • Creatine monohydrate CAS 6020-87-7
    Creatine monohydrate CAS 6020-87-7
  • Tetramethyluric acid CAS 2309-49-1 HPLC 60%
    Tetramethyluric acid CAS 2309-49-1 HPLC 60%
  • Berberine hydrochloride CAS 633-65-8
    Berberine hydrochloride CAS 633-65-8
All new products

News

  • CMC Expo exhibition area activities
    CMC Expo exhibition area activities

    The exhibition area is mainly launched in four topics, respectively, children's drug development strategy and application.

    2023-08-06

    Read More
  • Drug approval/project roadshow and supply and demand docking conference
    Drug approval/project roadshow and supply and demand docking conference

    MAH system has stimulated the circulation of approval documents, the conference provides a roadshow and demand release platform.

    2023-08-06

    Read More
  • The inhalant Conference of China Pharmaceutical Congress
    The inhalant Conference of China Pharmaceutical Congress

    Compared with ordinary formulations, inhalants have their particularities in dosage form, device and mode of action, high barriers to research and development of inhalation drug delivery, involving multidisciplinary integration.

    2023-08-06

    Read More
  • 2023 Dialogue on the production of domestic media
    2023 Dialogue on the production of domestic media

    In order to promote the healthy development of the media industry, the summit focused on the cutting-edge technology.

    2023-08-06

    Read More
  • The future of technology, AI empowers bioprocess development
    The future of technology, AI empowers bioprocess development

    Society is developing, science and technology is also changing, and the change of science and technology will inevitably bring unexpected "stimulus" to the field of medicine.

    2023-08-06

    Read More
  • 2023 China (Suzhou) Synthetic Biology Innovation Summit
    2023 China (Suzhou) Synthetic Biology Innovation Summit

    Synthetic biology is a subject that rationally designs, transforms and even synthesizes living systems from scratch according to specific goals under the guidance of engineering ideas to solve the problems of human food shortage, energy shortage, environmental pollution, medical health and other aspects.

    2023-08-06

    Read More
  • Antibody Drug Development Forum
    Antibody Drug Development Forum

    Antibody drugs are drugs prepared by antibody engineering technology based on cell engineering technology and gene engineering technology.

    2023-08-06

    Read More
  • Nucleic acid Drug Development Forum
    Nucleic acid Drug Development Forum

    In 1975, Gilbert and Sanger established DNA sequencing method. 1985 Mullis invented PCR technology.

    2023-08-06

    Read More
  • Small molecule New Drug Development Forum
    Small molecule New Drug Development Forum

    At present, the development of new drugs in China has gradually moved closer to the direction of original research and innovation in the true sense.

    2023-08-06

    Read More
  • 2023 The 5th CMC-China China International Biological & Chemical Pharmaceutical Expo
    2023 The 5th CMC-China China International Biological & Chemical Pharmaceutical Expo

    On August 3-4, 2023, the 5th CMC-China China International Biological & Chemical Pharmaceutical Expo in 2023 was held in Suzhou International Expo Center, co-organized by Junda Joint Venture and supported by Shenzhen Huarong.

    2023-08-06

    Read More
  • Jiaoze Industrial CDMO Project Signed for New Materials lndustrial Park in Haiyu Town, Changshu City
    Jiaoze Industrial CDMO Project Signed for New Materials lndustrial Park in Haiyu Town, Changshu City

    Wan Xiaojun, Vice Mayor of Changshu City; Changshu Development and Reform Commission, Changshu lndustry and Information Technology Bureau, Changshu Commerce Bureau, Changshu Natural Resources and Planning Bureau.

    2023-07-18

    Read More
  • Shanghai Jiaoze Industrial Co., Ltd Was Invited To Attend The Opening Ceremony Of The Changshu Branch Of The 2022 Suzhou Lnternational Elite Entrepreneurship Week
    Shanghai Jiaoze Industrial Co., Ltd Was Invited To Attend The Opening Ceremony Of The Changshu Branch Of The 2022 Suzhou Lnternational Elite Entrepreneurship Week

    On July 10,2022, the opening ceremony of the 14th Suzhou (Changshu) International Elite Entrepreneurship Week was held at the Changshu Convention Center, titled "Talent, Land, Wisdom, and Benefit Changshu".

    2023-07-18

    Read More
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • »
Links:

    Contact Us

    • Address: No.688 Qiushi Road, Jinshan Wei Town, Shanghai, China
    • Phone: +86-21-37318802
    • E-mail: [email protected]

    Inquiry For Price list

    For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.

    Latest News

    • Why Are 63% of Small Molecule CDMO Projects Delayed? Raw Material Sourcing & Regulatory Hurdles
      Why Are 63% of Small Molecule CDMO Projects Delayed? Raw Material Sourcing & Regulatory Hurdles 2025/07/08

      In 2025, delays in small molecule CDMO projects remain a persistent challenge—with 63% of programs failing to meet original timelines. Two recurring culprits stand out: raw material sourcing issues and evolving regulatory demands.

    • CDMO Small Molecule Innovations: Can AI-Driven Crystallization Design Replace Traditional Methods?
      CDMO Small Molecule Innovations: Can AI-Driven Crystallization Design Replace Traditional Methods? 2025/06/04

      Crystallization remains a critical step in small molecule drug development—impacting purity, bioavailability, and manufacturability. In 2025, CDMOs are increasingly exploring AI-driven crystallization design as a transformative alternative to traditional trial-and-error methods.

    Copyright © 2024 Shanghai Jiaoze Industrial Co., Ltd. - All Rights Reserved
    • Links
    • Sitemap
    • RSS
    • XML
    • Jiaoze Industrial
    • Jiaoze Industrial
    • Jiaoze Industrial
    • Jiaoze Industrial
    • Jiaoze Industrial